Park Ha Biological (BYAH) CFO Zhu Xiaoyan Receives Award

What Happened Zhu Xiaoyan, Chief Financial Officer of Park Ha Biological Technology Co., Ltd. (BYAH), was granted/acquired 112,500 Class A ordinary shares on August 3, 2026. The reported price per share is $0.18, for a total reported value of $20,250. The transaction is reported as an acquisition/award under the company’s 2026 Share Incentive Plan.

Key Details

• Transaction date: August 3, 2026; Form 4 filed August 7, 2026.
• Transaction type/code: Award/Acquisition (A).
• Shares and price: 112,500 shares at $0.18 each; total $20,250.
• Footnote F1: Shares issued pursuant to the 2026 Share Incentive Plan.
• Footnote F2: A 1-for-8 reverse stock split became effective August 6, 2026; the reported share counts have been adjusted to reflect that split.
• Shares owned after transaction: Not specified in the summary data provided on this filing.

Context This filing reports a grant/acquisition of company stock to an officer rather than a sale. Grants under incentive plans are common executive compensation; they represent an acquisition but do not on their own indicate the insider’s intent to buy or sell additional shares. Check the full SEC Form 4 (Accession 0001213900-26-086433) for any additional details or ownership totals.